Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411

K-Number: K010389 · 2001-03-23

ApplicantChad Therapeutics, Inc.
Decision Date2001-03-23
Product CodeNFB
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411 is the device name listed in this FDA 510(k) record. The listed applicant is Chad Therapeutics, Inc.. It received FDA 510(k) clearance on 2001-03-23 under 510(k) number K010389. The device is classified under product code NFB. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411?

CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411 is a medical device that received FDA 510(k) clearance on 2001-03-23. The listed applicant is Chad Therapeutics, Inc.. The 510(k) number is K010389.

When did CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411 receive FDA 510(k) clearance?

CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411 received FDA 510(k) clearance on 2001-03-23, under 510(k) number K010389.

Who is the listed applicant for CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411?

The FDA 510(k) record lists Chad Therapeutics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411?

The FDA product code for CHAD THERAPEUTICS OXYMATIC MODEL 401 AND OXYMATIC MODEL 411 is NFB.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Chad Therapeutics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K081176FLOCHANNELK070740CHAD THERAPEUTICS BONSAI MODEL 800K042142CHAD THERAPEUTICS LOTUS, MODELS OM-700 AND OM-700SK033364CHAD THERAPEUTICS SAGEK020475CHAD THERAPEUTICS OXYPENUMATIC CYPRESS MODEL 511K013472TOTAL O2

View all 17 devices →

Related Devices (Code: NFB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K250322Respond OC Conserving Regulator (130-0800)Responsive RespiratoryK220591ProximaDynasthetics, LLCK221014Effortless Oxygen Conserver System Models Effortless Pro and Effortless MobileEffortless Oxygen, LLCK200401ApogeeIncoba Ltd D/B/A DynarisK151506Demand Nasal Oxygen Cannula, Modified Demand Nasal Oxygen CannulaSalter LabsK131023THERAFLOW SINGLE LUMEN AND THERAFLOW DUAL LUMENMedical Products, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑